Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir.
Jiang X, Su H, Shang W, Zhou F, Zhang Y, Zhao W, Zhang Q, Xie H, Jiang L, Nie T, Yang F, Xiong M, Huang X, Li M, Chen P, Peng S, Xiao G, Jiang H, Tang R, Zhang L, Shen J, Xu Y.
Jiang X, et al. Among authors: yang f.
Nat Commun. 2023 Oct 13;14(1):6463. doi: 10.1038/s41467-023-42102-y.
Nat Commun. 2023.
PMID: 37833261
Free PMC article.